Unknown

Dataset Information

0

IgA Nephropathy and Focal Segmental Glomerulosclerosis in a Patient With High-Risk Apolipoprotein L1 Genotype.

ABSTRACT:

SUBMITTER: Ray J 

PROVIDER: S-EPMC9751699 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

IgA Nephropathy and Focal Segmental Glomerulosclerosis in a Patient With High-Risk Apolipoprotein L1 Genotype.

Ray Justina J   Smith Steven S   Lefferts Sean S   Meliambro Kristin K   Salem Fadi F   Campbell Kirk N KN  

Kidney international reports 20220903 11

Similar Datasets

Unknown Focal Segmental Glomerulosclerosis.
| S-EPMC5338705 | biostudies-literature
Unknown APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
| S-EPMC3231787 | biostudies-literature
Unknown APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis.
| S-EPMC8524347 | biostudies-literature
Unknown Genetics of focal segmental glomerulosclerosis.
| S-EPMC2467504 | biostudies-literature
Unknown Novel Treatment Paradigms: Focal Segmental Glomerulosclerosis.
| S-EPMC9831941 | biostudies-literature
Unknown Galactose treatment in focal segmental glomerulosclerosis.
| S-EPMC3972262 | biostudies-literature
Unknown A misprocessed form of Apolipoprotein A-I is specifically associated with recurrent Focal Segmental Glomerulosclerosis.
| S-EPMC6981185 | biostudies-literature
Unknown Safety and efficacy of sparsentan versus irbesartan in focal segmental glomerulosclerosis and IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials.
| S-EPMC11429118 | biostudies-literature
Unknown Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life.
| S-EPMC3306823 | biostudies-literature
Unknown Phenotype-Genotype Correlations in Three Different Cases of Adult-Onset Genetic Focal Segmental Glomerulosclerosis.
| S-EPMC10743622 | biostudies-literature